The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2020
Filed:
Aug. 11, 2017
Applicant:
Biontech Ag, Mainz, DE;
Inventors:
Ozlem Tureci, Mainz, DE;
Ugur Sahin, Mainz, DE;
Sandra Schneider, Stutensee, DE;
Gerd Helftenbein, Germunden, DE;
Volker Schluter, Neuried, DE;
Dirk Usener, Wiesbaden, DE;
Philippe Thiel, Planegg, DE;
Michael Koslowski, Mainz, DE;
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/686 (2018.01); C12Q 1/6886 (2018.01); C07K 14/47 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 14/4748 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C12Q 1/686 (2013.01); A61K 39/395 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); G01N 33/53 (2013.01);
Abstract
The invention relates to the identification of gene products that are the result of tumor-associated expression and the nucleic acids encoding the same. The invention also relates to the therapy and diagnosis of diseases wherein these gene products are the result of an aberrant tumor-associated expression. The invention also relates to the proteins, polypeptides and peptides that are the result of tumor-associated expression and to the nucleic acids encoding the same.